acc

Interviews and expert commentary tagged “acc” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Bivalirudin For Angioplasty: Expensive Heparin?
Audio Journal of Oncology

Bivalirudin For Angioplasty: Expensive Heparin?

Tony Gershlick Tony Gershlick, University of Leicester Adnan Kastrati, Deutsches Herzzentrum, Munich Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing deat

30 April 2008
0:00
Remove Thrombus Before Primary Angioplasty!
Audio Journal of Oncology

Remove Thrombus Before Primary Angioplasty!

Felix Zijlstra Felix Zijlstra, University Medical Center Groningen, The Netherlands Thrombus aspiration before percutaneous coronary intervention for acute myocardial infarction has multiple benefits,

15 April 2008
0:00
Never Too Old For Hypertension Treatment!
Audio Journal of Oncology

Never Too Old For Hypertension Treatment!

Nigel Beckett Nick Boon Nigel Beckett, Imperial College, London COMMENT: Nick Boon, British Cardiovascular Society, London Even very old patients benefit greatly if you treat their hypertension. This

8 April 2008
0:00
Routine Angioplasty Recommended After Thrombolysis
Audio Journal of Oncology

Routine Angioplasty Recommended After Thrombolysis

Warren Cantor Tony Gershlick REFERENCE: Abstract 2404-3 SCAI-ACCi2 Late-Breaking Clinical Trials II: Acute Myocardial Infarction Warren Cantor, University of Toronto COMMENT: Tony Gershlick, Leicester

6 April 2008
0:00
Audio Journal of Cardiovascular Medicine: “EXACT” Study: Carotid Stenting Benefits Are Maintained in the Real World
Audio Journal of Oncology

Audio Journal of Cardiovascular Medicine: “EXACT” Study: Carotid Stenting Benefits Are Maintained in the Real World

WILLIAM GRAY, Columbia University, New York REFERENCE: Abstract 2409-5, American College of Cardiolgy New Orleans The benefits of carotid stenting as compared with surgery have been maintained in real

27 March 2007
0:00
“RADIANCE-1” Study:  Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia
Audio Journal of Oncology

“RADIANCE-1” Study: Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia

JOHN KASTELEIN, Academic Medical Center, Amsterdam REFERENCE: Abstract 407-7, American College of Cardiolgy New Orleans A drug which raises HDL and reduces circulating levels of LDL has nevertheless f

27 March 2007
0:00
“ERASE” Trial: Infusions of Reconstituted HDL Treat Atherosclerosis in Patients with Acute Coronary Syndromes
Audio Journal of Oncology

“ERASE” Trial: Infusions of Reconstituted HDL Treat Atherosclerosis in Patients with Acute Coronary Syndromes

JEAN-CLAUDE TARDIF, Montreal Heart Institute REFERENCE: Abstract 405-10, American College of Cardiolgy New Orleans Improvements in atheroma plaque have been achieved by infusing patients who have acut

27 March 2007
0:00
COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk
Audio Journal of Oncology

COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk

STEVEN NISSEN, Cleveland Clinic, OH REFERENCE: N Engl J Med 2007 356 Reporting from: American College of Cardiolgy New Orleans Two big studies published in the New England Journal of Medicine and pres

26 March 2007
0:00
Rapid Genotype Assay for Individualized Warfarin Dosing
Audio Journal of Oncology

Rapid Genotype Assay for Individualized Warfarin Dosing

Jeffrey Anderson Douglas Zipes JEFFREY ANDERSON, University of Utah, Salt Lake City COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis REFERENCE: Abstract 1020-89, American College of Cardiol

25 March 2007
0:00
Thrombin Receptor Antagonist: Advantages in Percutaneous Coronary Intervention?
Audio Journal of Oncology

Thrombin Receptor Antagonist: Advantages in Percutaneous Coronary Intervention?

DAVID MOLITERNO, University of Kentucky, Lexington REFERENCE: American College of Cardiolgy New Orleans, March 24th Late Breaking Trials An oral thrombin receptor antagonist, SCH 530348 has proved saf

25 March 2007
0:00